Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc

摘要

This is a single observational study without controls, providing Class IV evidence for the effectiveness of maraviroc in the treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome in MS.